Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #9,781 to #9,830.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Renovascular disease echocardiography or ultrasound (1 revision)
  2. Renovascular disease electrocardiogram (1 revision)
  3. Renovascular disease epidemiology and demographics (1 revision)
  4. Renovascular disease future or investigational therapies (1 revision)
  5. Renovascular disease historical perspective (1 revision)
  6. Renovascular disease laboratory findings (1 revision)
  7. Renovascular disease medical therapy (1 revision)
  8. Renovascular disease other diagnostic studies (1 revision)
  9. Renovascular disease overview (1 revision)
  10. Renovascular disease pathophysiology (1 revision)
  11. Renovascular disease physical examination (1 revision)
  12. Renovascular disease primary prevention (1 revision)
  13. Renovascular disease risk factors (1 revision)
  14. Renovascular disease screening (1 revision)
  15. Renovascular disease secondary prevention (1 revision)
  16. Renovascular disease surgery (1 revision)
  17. Renovo, plc. (1 revision)
  18. Renzapride (1 revision)
  19. René Spitz (1 revision)
  20. Repaglinide (patient information) (1 revision)
  21. Replication protein A1 (1 revision)
  22. Replication protein A2 (1 revision)
  23. Replication protein A3 (1 revision)
  24. Repolarization (1 revision)
  25. Reporting results (1 revision)
  26. Repotrectinib (1 revision)
  27. Representational systems (NLP) (1 revision)
  28. Representative agent (1 revision)
  29. Repressor lexA (1 revision)
  30. Reprimo (1 revision)
  31. Reproduction (1 revision)
  32. Reproductive endocrinology (1 revision)
  33. Reproductive endocrinology and infertility (1 revision)
  34. Reproductive system (1 revision)
  35. Reproductive system disease (1 revision)
  36. Reproductive technology (1 revision)
  37. Reptile (1 revision)
  38. Repugnant market (1 revision)
  39. Research (1 revision)
  40. Research Defence Society (1 revision)
  41. Research ethics (1 revision)
  42. Research funding (1 revision)
  43. Resection (1 revision)
  44. Reserpine (patient information) (1 revision)
  45. Residency (medicine) (1 revision)
  46. Resiniferatoxin (1 revision)
  47. Resistant starch (1 revision)
  48. Resistivity (1 revision)
  49. Resistor (1 revision)
  50. Reslivizumab (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"